Acute illness in children with secondary adrenal insufficiency

Rosemary Louise Rushworth1, Nikki Gouvoussis1, Thomas Goubar1

  • 1School of Medicine, Sydney, The University of Notre Dame, Sydney, Australia.

Clinical Endocrinology
|February 5, 2021
PubMed

Insights

Children with secondary adrenal insufficiency (SAI) face significant illness. Those with comorbid diabetes insipidus (DI) experience more hospitalizations and shorter stress dose use, suggesting a need for targeted education.

Area of Science:

  • Pediatric Endocrinology
  • Internal Medicine
  • Clinical Research

Background:

  • Secondary adrenal insufficiency (SAI) is a rare pediatric condition linked to substantial morbidity.
  • The precise causes of increased illness severity in SAI patients remain unclear, necessitating further investigation.

Purpose of the Study:

  • To investigate the characteristics and healthcare utilization of children with SAI.
  • To identify factors associated with increased morbidity in pediatric SAI patients.

Main Methods:

  • A retrospective cohort study analyzed emergency department attendances for acute illness in pediatric SAI patients in Sydney, Australia (2004-2016).
  • Data collected included demographic, clinical, and physiological characteristics, as well as pre-hospital management strategies.

Main Results:

  • The study included 168 presentations by 47 children with SAI. Comorbid diabetes insipidus (DI) was present in 46.8% of patients.
  • Patients with comorbid DI had higher admission rates (86.7% vs. 60.2%), longer hospital stays (6.5 vs. 2.5 days), and lower reported stress dose use (58.7% vs. 78.5%).
  • The rate of medically-diagnosed adrenal crisis (AC) was 3.68 ACs/100 patient-years. Previous hospital attendance was linked to increased stress dose use.

Conclusions:

  • Secondary adrenal insufficiency contributes to significant childhood morbidity.
  • Comorbid DI in pediatric SAI is associated with increased hospitalizations, prolonged stays, and reduced pre-emergent stress dose administration.
  • Targeted educational interventions for SAI patients with comorbid DI may mitigate morbidity.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.4K
Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.8K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
429
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
337
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
105